Met Life Investment Management, LLC Spero Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.87 - $15.15 $78,518 - $151,151	-9,977 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$13.09 - $18.77 $130,598 - $187,268	9,977 New	9,977 $159,000
Q3 2021 Jun 21, 2023	BUY	$13.03 - $19.51 $130,000 - $194,651	9,977 New	9,977 $183,000
Q2 2021 May 17, 2024	BUY	$12.22 - $15.79 $97,136 - $125,514	7,949 Added 391.96%	9,977 $139,000
Q2 2021 Jun 21, 2023	BUY	$12.22 - $15.79 $121,918 - $157,536	9,977 New	9,977 $139,000
Q2 2021 Mar 22, 2023	BUY	$12.22 - $15.79 $97,136 - $125,514	7,949 Added 391.96%	9,977 $139,000
Q2 2021 Aug 16, 2021	BUY	$12.22 - $15.79 $97,136 - $125,514	7,949 Added 391.96%	9,977 $139,000
Q1 2021 May 17, 2024	BUY	$13.23 - $21.48 $26,830 - $43,561	2,028 New	2,028 $29,000
Q1 2021 Jun 26, 2023	BUY	$13.23 - $21.48 $26,830 - $43,561	2,028 New	2,028 $29.9 Million
Q1 2021 Mar 22, 2023	SELL	$13.23 - $21.48 $97,928 - $158,994	-7,402 Reduced 78.49%	2,028 $29,000
Q1 2021 May 14, 2021	SELL	$13.23 - $21.48 $97,928 - $158,994	-7,402 Reduced 78.49%	2,028 $30,000
Q4 2020 May 24, 2024	BUY	$11.65 - $22.07 $21,657 - $41,028	1,859 Added 24.55%	9,430 $182,000
Q4 2020 Jun 22, 2023	BUY	$11.65 - $22.07 $109,859 - $208,120	9,430 New	9,430 $182,000
Q4 2020 Mar 22, 2023	BUY	$11.65 - $22.07 $21,657 - $41,028	1,859 Added 24.55%	9,430 $182,000
Q4 2020 Feb 16, 2021	BUY	$11.65 - $22.07 $109,859 - $208,120	9,430 New	9,430 $183,000
Q3 2020 Nov 13, 2020	SELL	$8.96 - $14.12 $67,836 - $106,902	-7,571 Closed	0 $0
Q2 2020 May 24, 2024	BUY	$7.27 - $14.18 $55,041 - $107,356	7,571 New	7,571 $102 Million
Q2 2020 Jun 26, 2023	BUY	$7.27 - $14.18 $55,041 - $107,356	7,571 New	7,571 $102,000
Q2 2020 Mar 22, 2023	BUY	$7.27 - $14.18 $55,041 - $107,356	7,571 New	7,571 $102,000
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $55,041 - $107,356	7,571 New	7,571 $102,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.23 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.52 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.16 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$921,799
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$838,201
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $30.2M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account